CellProthera, a clinical-stage company developing regenerative cell therapies for ischemic diseases, has announced its s...
Japan-based pharma firm Shionogi has announced that Shionogi China, a Shionogi group company in China, has entered into ...
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.06 b...
PeptiDream Inc., a public biopharmaceutical company based in Kawasaki, Japan, focused on the discovery and development o...
Japan-based Otsuka Pharmaceutical has announced that Otsuka BioVentures, LLC (OBV), a corporate venture capital (CVC) fi...
AI Proteins, Inc., a US-based biotechnology company that utilises computational de novo protein design to create therape...
NovAccel, Inc., a Japanese deep-tech company developing proprietary superconducting accelerator technology for medical r...
Japan-based TOHO HOLDINGS has invested in AdipoSeeds, Inc., a venture company spun off from Keio University School of Me...
Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...
Forty years on, a different question When BioJapan opened its doors for the first time in 1986, Japan's pharmaceutical ...
ITOCHU Corporation has signed a capital alliance agreement with MOLCURE Inc., which possesses AI-driven drug discovery t...
Japan-based Ono Pharmaceutical has entered into an exclusive license agreement with Biohaven, together with its wholly o...
Japan-based Shimadzu Corporation has started the development and validation of a mass spectrometry (MS) solution for cor...
If the opening day of BioJapan 2026 diagnosed the gap between Japanese science and global deals, the second day at PACIF...
Japan-based Shionogi & Co. is entering into an agreement to acquire IntraBio Inc, a biopharmaceutical company develo...
Yokohama, 7 October 2026 | BioJapan 2026, Regenerative Medicine JAPAN and healthTECH JAPAN, PACIFICO Yokoham...
Japan-based Chiba University, Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), l...
Docquity, the Singapore-based clinical AI platform for more than 75% of verified doctors across Asia, has announced...
Japanese startup Celaid Therapeutics Inc. has announced the completion of the second close of its Series B financing rou...
Reprocell Inc. has entered into a basic agreement with Toho Holdings toward a partnership concerning the domestic distri...
Japan’s Chugai Pharmaceutical and InxMed (Hong Kong) have entered into a worldwide license agreement regarding SPY...
United Immunity, a clinical stage biotechnology company, has raised a total of ¥2.2 billion in private financing, co...
Denmark-based Lundbeck has received marketing authorisation from Japan’s Ministry of Health, Labour and Welfare fo...
India-based Gujarat Themis Biosyn Limited (GTBL) has announced the completion of the acquisition of 100% equity sharehol...
Eisai Co. and Biogen Inc. have announced that LEQEMBI® Pen, the subcutaneous (SC) formulation of the anti-amyloid be...
